GlassScriptPhysician profile
Andre Robert Sanschagrin
NPI 1801872221
$564.00
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $199 · 2021: $81.06 · 2024: $45.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $45.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $45.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $308.14 | 2019-2021 | |
| Pfizer INC. | $39.31 | 2019 | |
| Radius Health, INC. | $33.88 | 2019 | |
| Abbott Laboratories | $27.62 | 2024 | Freestyle Libre 3 |
| Neotract INC. | $20.74 | 2019 | |
| Novartis Pharmaceuticals Corporation | $20.66 | 2019 | |
| Sanofi-Aventis U.S. LLC | $18.77 | 2021 | |
| Glaxosmithkline, LLC. | $18.35 | 2024 | Shingrix, Arexvy |
| Allergan, INC. | $15.85 | 2020 | |
| Novo Nordisk INC | $15.69 | 2020 | |
| Sanofi Pasteur INC. | $15.58 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $15.40 | 2019 | |
| Seqirus USA INC | $14.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Sanschagrin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.